The event is specifically designed for non-accountants and will enhance understanding of business strategies, accounting fundamentals, and vocabulary used by management, investors, auditors, and bankers. Practical advice and applications of information to actual situations and financial reports will provide participants with opportunities to immediately implement growth and broaden capabilities.
Nicholson’s session, “Rise or Die: Financial Distress,” will focus on the following topics:
- Analyze the indicators and causes of financial distress, including solvency and liquidity
- Who are the stakeholders and other possibly affected parties?
- Evaluate restructuring alternatives, including when does a bankruptcy filing make sense?
- Rescue financing
- Case Study: Discuss a company in distress and strategies utilized to improve the situation
For more information and to register, please visit PLI’s website.
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.